Frontlight ResearchEarly access
Not yet recruitingPhase 3
Efficacy of Dexmedetomidine on Emergence Delirium in Children Undergoing Adenotonsillectomy: A Double-Blind Randomized Controlled Trial with Heart Rate Variability and Electroencephalography-Guided Anesthesia
Key facts
- Who runs it
- Akershus University Hospital
- Where
- Norway1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 3
- People taking part
- 255 people, planned
- Started
- 1 Mar 2026
- Expected to end
- 1 Mar 2028
- Type of study
- Interventional
- Record updated
- 23 October 2026
Who can take part
- Age
- Up to 17 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- American Society of Anesthesiologists I and II
- Children aged 1–7 years
- Scheduled to undergo adenoidectomy, tonsillectomy, tonsillotomy, including any concomitant otologic procedures, such as myringotomy, tympanostomy tube insertion, and perioperative hearing assessment, or any combination of these procedures
Who cannot take part
- Known allergies or intolerances to Dexmedetomidine
- Acute cerebrovascular conditions
- Neuropsychiatric diagnoses that include: intellectual disabilities, disorders of psychological development, and behavioural and emotional disorders with onset usually occurring in childhood and adolescence. As defined in ICD-10, F70 to F98
- Clinically unfit for general anesthesia
- Daily use of analgesics
- Under investigation for a neuropsychiatric diagnosis as defined in exclusion point number 3
- Children whose legally authorized representative does not speak and read sufficient Norwegian or English
- Missing consent from the participant’s legally authorized representatives
- Second- or third-degree atrioventricular block, unless the patient has a pacemaker
- Uncontrolled hypotension
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To evaluate if dexmedetomidine reduces the risk of emergence delirium in children aged 1-7 years old undergoing adenotonsillectomy during general anesthesia guided by heart rate variability and electroencephalogram monitoring.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Record updated
- 23 October 2026